SCIENTIFIC REPORT 2010 - 2011 - IOV

FOREWORD 5
THE INSTITUTE 9
Chief Officer Address 13
The IOV Governance 16
CLINICAL ACTIVITY ORGANIZATION 19
Chief Medical Officer Report 21
Clinical Activity Data 24
Multidisciplinary Groups 28
THE DEPARTMENTS 31
Department of Clinical Oncology 33
Clinical Oncology 1 34
Clinical Oncology 2 46
Evaluation and Introduction of New Drugs
in Cancer Therapy 54
Department of Surgery 57
Surgical Oncology 58
Breast Surgery 64
Melanoma and Soft Tissue Tumors 68
Diagnostic and Operative Endoscopy 76
Anesthesiology 82
Department of Imaging, Radiology and Pathology 89
Radiology 90
Breast Imaging 96
Pathology 104
Department of Radiotherapy and Nuclear Medicine 107
Radiotherapy and Nuclear Medicine 108
Medical Physics 120
Department of Experimental, Laboratory and
Translational Oncology 127
Immunology and Molecular Oncology 128
Hereditary Endrocrine Cancer Unit 154
CONTENTS
CONTENTS
3
Department of Services 161
Pharmacy 162
Cardiology 168
Psycho-Oncology 172
Tumor Registry 178
THE RESEARCH 185
Scientific Director Address 187
General Considerations 188
Scientific Directorate Organization 191
SWOT Analysis 195
Research: Input and Output 197
Clinical Trials and Biostatistics Unit 202
Strategic Scientific Options 209
Pharmacogenomics 212
Cancer Stem Cells 214
RESEARCH ACTIVITY REPORT 217
Line 1 - Tumor Epidemiology and Prevention 218
Introduction 218
Workflow Project List 219
Line 2 - Mechanisms of Cancerogenesis 220
Introduction 220
Workflow Project List
Line 3 - Instrumental and Molecular Approaches
221
for Diagnosis, Staging and Follow-Up 222
Introduction 222
Workflow Project List
Line 4 - Innovative Therapeutic Approaches:
223
Chemotherapy, Radiotherapy and Surgery 226
Introduction 226
Workflow Project List 227